Xebio Holdings Statistics
Total Valuation
Xebio Holdings has a market cap or net worth of JPY 45.07 billion. The enterprise value is 37.74 billion.
| Market Cap | 45.07B |
| Enterprise Value | 37.74B |
Important Dates
The next estimated earnings date is Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Xebio Holdings has 41.38 million shares outstanding. The number of shares has decreased by -5.43% in one year.
| Current Share Class | 41.38M |
| Shares Outstanding | 41.38M |
| Shares Change (YoY) | -5.43% |
| Shares Change (QoQ) | -0.69% |
| Owned by Insiders (%) | 8.38% |
| Owned by Institutions (%) | 13.28% |
| Float | 20.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.18 |
| PB Ratio | 0.37 |
| P/TBV Ratio | 0.41 |
| P/FCF Ratio | 18.32 |
| P/OCF Ratio | 4.21 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.39, with an EV/FCF ratio of 15.34.
| EV / Earnings | -42.93 |
| EV / Sales | 0.15 |
| EV / EBITDA | 3.39 |
| EV / EBIT | 7.74 |
| EV / FCF | 15.34 |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.91 |
| Quick Ratio | 0.47 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.59 |
| Debt / FCF | 2.68 |
| Interest Coverage | 58.04 |
Financial Efficiency
Return on equity (ROE) is -0.80% and return on invested capital (ROIC) is 4.44%.
| Return on Equity (ROE) | -0.80% |
| Return on Assets (ROA) | 1.50% |
| Return on Invested Capital (ROIC) | 4.44% |
| Return on Capital Employed (ROCE) | 3.60% |
| Revenue Per Employee | 100.49M |
| Profits Per Employee | -353,722 |
| Employee Count | 2,485 |
| Asset Turnover | 1.23 |
| Inventory Turnover | 1.80 |
Taxes
In the past 12 months, Xebio Holdings has paid 899.00 million in taxes.
| Income Tax | 899.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.61% in the last 52 weeks. The beta is 0.16, so Xebio Holdings's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | -11.61% |
| 50-Day Moving Average | 1,063.54 |
| 200-Day Moving Average | 1,135.04 |
| Relative Strength Index (RSI) | 57.15 |
| Average Volume (20 Days) | 71,805 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Xebio Holdings had revenue of JPY 249.73 billion and -879.00 million in losses. Loss per share was -21.02.
| Revenue | 249.73B |
| Gross Profit | 96.82B |
| Operating Income | 4.88B |
| Pretax Income | -90.00M |
| Net Income | -879.00M |
| EBITDA | 11.12B |
| EBIT | 4.88B |
| Loss Per Share | -21.02 |
Balance Sheet
The company has 14.20 billion in cash and 6.58 billion in debt, with a net cash position of 7.61 billion or 183.94 per share.
| Cash & Cash Equivalents | 14.20B |
| Total Debt | 6.58B |
| Net Cash | 7.61B |
| Net Cash Per Share | 183.94 |
| Equity (Book Value) | 120.80B |
| Book Value Per Share | 2,912.30 |
| Working Capital | 60.55B |
Cash Flow
In the last 12 months, operating cash flow was 10.71 billion and capital expenditures -8.25 billion, giving a free cash flow of 2.46 billion.
| Operating Cash Flow | 10.71B |
| Capital Expenditures | -8.25B |
| Free Cash Flow | 2.46B |
| FCF Per Share | 59.45 |
Margins
Gross margin is 38.77%, with operating and profit margins of 1.95% and -0.35%.
| Gross Margin | 38.77% |
| Operating Margin | 1.95% |
| Pretax Margin | -0.04% |
| Profit Margin | -0.35% |
| EBITDA Margin | 4.45% |
| EBIT Margin | 1.95% |
| FCF Margin | 0.99% |
Dividends & Yields
This stock pays an annual dividend of 35.00, which amounts to a dividend yield of 3.24%.
| Dividend Per Share | 35.00 |
| Dividend Yield | 3.24% |
| Dividend Growth (YoY) | 7.69% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 5.43% |
| Shareholder Yield | 8.67% |
| Earnings Yield | -1.95% |
| FCF Yield | 5.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 28, 2006. It was a forward split with a ratio of 1.5.
| Last Split Date | Mar 28, 2006 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
Xebio Holdings has an Altman Z-Score of 2.72 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.72 |
| Piotroski F-Score | 6 |